spacer
home > ict > autumn 2009 > infrastructure and experience: the kiwi way
PUBLICATIONS
International Clinical Trials

Infrastructure and Experience: The Kiwi Way

 

New Zealand is an island country in the south-west Pacific comparable in size to the UK, the Philippines and the US state of Colorado. The capital is Wellington and the largest city and principal port is in Auckland. New Zealand boasts a multicultural population of around 4.2 million people. Seventy per cent of the population live in towns or cities, which ensures good access to clinical trial centres for most of the country’s population. New Zealand’s small size and location has helped mould the country into becoming practical and innovative. The need to be globally focused in whatever New Zealand does is paramount, and this is demonstrated by collaborations with leading research institutes and companies, and a number of trade agreements.

CENTRAL ETHICS REVIEW

Within New Zealand, the health and disability ethics committees provide protection for research participants in the health and disability sector (1). Ethics committee reviews are primarily designed to:

  • Prevent studies that pose an unacceptable risk of harm to participants from going ahead
  • Ensure that all participants in research are aware of what their participation will involve and have given informed consent

New Zealand has a central review system; ethical review of health and disability research in New Zealand is carried out by seven health and disability ethics committees.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer

Christine Weston is currently Director of Infinity Consulting Ltd, an independent clinical research consultant. She has 14 years’ experience in the New Zealand clinical trial industry, including nine years as Head of Clinical Research for a multinational pharma company.

Shaun Holt is the Director and founder of Clinicanz, New Zealand’s only site management organisation. Previously, he was the founder of P3 Research and Research Review. Shaun holds Pharmacy and Medicine degrees, has been the Principal Investigator in over 50 clinical trials, and has over 50 publications in medical literature.

spacer
Christine Weston
spacer
spacer
spacer
Shaun Holt
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

PCI Pharma Services Announces Further Expansion in San Diego to Maintain Industry-Leading Quality, Service and Flexibility

Philadelphia, PA – June 4, 2019 PCI Pharma Services (PCI), a leading biopharmaceutical outsourcing services provider, has announced the growth of its West Coast Clinical operations with expansion into its third facility in San Diego.
More info >>

White Papers

The Use of Stainless Steel Equipment Within Laboratories and Clean Rooms

Teknomek Ltd

Teknomek explains why stainless steel is the material of choice for laboratories and hygienic manufacturing.
More info >>

 
Industry Events

Clinical Innovation Partnerships

11-12 September 2019, Hotel Palace, Berlin

Clinical Innovation Partnerships is the only event for senior clinical operations and procurement professionals driving innovation in their clinical trials. It is where the pharma, CRO and vendor clinical trials ecosystem meet to drive innovation in digitalisation, tech and partnering to improve patient experience and reduce trial cost and time.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement